No Data
No Data
Aridis Pharmaceuticals Continuing to Explore 'Multiple Paths to Monetize' Assets
Cystic Fibrosis Market Is Projected to Boost by 2034, Predicts DelveInsight | Key Companies - Verona Pharmaceuticals, Vertex Pharmaceuticals, Krystal Biotech, Aridis Pharmaceuticals, BiomX, Inc., Boehringer Ingelheim
Express News | Aridis- in Discussions With Other Pharmaceutical Cos and Investment Firms on Possible Partnerships and Investments on Its Apex Platform Technology
Express News | Aridis - in Discussions With Pharmaceutical Cos,Investment Firms on Possible Partnerships on Its Clinical Product Candidates Ar- 301, Ar-320, Ar-501
Express News | Aridis Provides Corporate Update
Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders Until January 12, 2024